Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Preeclampsia Prevention
NCT04755322Completed
- Sponsor
- Assiut University
- Start
- Mar 2021
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of hydroxychloroquine in preeclampsia, sponsored by Assiut University. Primary endpoint: number of cases of preeclampsia at 9 months. Started Mar 2021; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04755322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04755322.